B

Broncus Holding Corp
HKEX:2216

Watchlist Manager
Broncus Holding Corp
HKEX:2216
Watchlist
Price: 2.49 HKD -2.35% Market Closed
Market Cap: 1.3B HKD
Section:
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one Broncus Holding Corp stock under the Base Case scenario is 0.93 HKD. Compared to the current market price of 2.49 HKD, Broncus Holding Corp is Overvalued by 62%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
0.93 HKD
Overvaluation 62%
Relative Value
Price
B
Worst Case
Base Case
Best Case

Valuation Multiples

27.7
P/S
P/S
Price to Sales
27.7
vs History
11
vs Industry
20
Median 3Y
6.7
Median 5Y
8.6
Industry
2.3
Forward
14
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-2.6
Median 5Y
-2.3
Industry
22.5
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
Median 3Y
-3.1
Median 5Y
-4.3
Industry
14.6
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-2.9
Median 5Y
-4.1
Industry
21.6
More Details
1
P/B
P/B
Price to Book Value
1
vs History
13
vs Industry
81
Median 3Y
0.4
Median 5Y
0.4
Industry
2.2
More Details
6.2
EV/S
EV/S
Enterprise Value to Sales
6.2
vs History
11
vs Industry
Median 3Y
-9.3
Median 5Y
-9
Industry
2.6
Forward
3.2
More Details
8.6
EV/GP
EV/GP
Enterprise Value to Gross Profit
8.6
vs History
11
vs Industry
Median 3Y
-12.1
Median 5Y
-11.4
Industry
5.2
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
51
Median 3Y
3.4
Median 5Y
2.5
Industry
12
Forward
88.6
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
49
Median 3Y
3.1
Median 5Y
2.3
Industry
17
Forward
-3.5
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
49
Median 3Y
3.6
Median 5Y
2.3
Industry
14.8
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
41
Median 3Y
3.5
Median 5Y
2.2
Industry
18.7
More Details
1.1
EV/IC
EV/IC
Enterprise Value to IC
1.1
vs History
19
vs Industry
Median 3Y
-2.6
Median 5Y
-2.5
Industry
1.9
More Details

Multiples Across Competitors

Competitors Multiples
Broncus Holding Corp Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Broncus Holding Corp
HKEX:2216
1.3B HKD 27.7 -11.1 -2.1 -1.9
US
Abbott Laboratories
NYSE:ABT
224.1B USD 5.1 16 20.4 28.4
US
Intuitive Surgical Inc
NASDAQ:ISRG
205.6B USD 21.4 74.8 57.4 70
US
Boston Scientific Corp
NYSE:BSX
150.6B USD 7.8 53.9 31.4 42.7
US
Stryker Corp
NYSE:SYK
141.9B USD 5.8 48.2 23.5 28.4
IE
Medtronic PLC
NYSE:MDT
135B USD 3.9 28.3 15.8 22.9
US
IDEXX Laboratories Inc
NASDAQ:IDXX
60.2B USD 14.5 58.6 42.1 46.6
US
Becton Dickinson and Co
NYSE:BDX
55.6B USD 2.5 33.1 13.3 24.3
DE
Siemens Healthineers AG
XETRA:SHL
48B EUR 2.1 22.4 12.8 18
US
Edwards Lifesciences Corp
NYSE:EW
50.3B USD 8.6 36.8 26.3 28.9
US
Resmed Inc
NYSE:RMD
37.3B USD 7.1 26 18.6 20.6
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CN
B
Broncus Holding Corp
HKEX:2216
Average EV/EBITDA: 26.2
Negative Multiple: -2.1 		N/A N/A
US
Abbott Laboratories
NYSE:ABT
20.4
13%
1.6
US
Intuitive Surgical Inc
NASDAQ:ISRG
57.4
25%
2.3
US
Boston Scientific Corp
NYSE:BSX
31.4
21%
1.5
US
Stryker Corp
NYSE:SYK
23.5
13%
1.8
IE
Medtronic PLC
NYSE:MDT
15.8
8%
2
US
IDEXX Laboratories Inc
NASDAQ:IDXX
42.1
13%
3.2
US
Becton Dickinson and Co
NYSE:BDX
13.3
11%
1.2
DE
Siemens Healthineers AG
XETRA:SHL
12.8
11%
1.2
US
Edwards Lifesciences Corp
NYSE:EW
26.3
12%
2.2
US
Resmed Inc
NYSE:RMD
18.6
11%
1.7
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CN
B
Broncus Holding Corp
HKEX:2216
Average EV/EBIT: 33.1
Negative Multiple: -1.9 		N/A N/A
US
Abbott Laboratories
NYSE:ABT
28.4
23%
1.2
US
Intuitive Surgical Inc
NASDAQ:ISRG
70
26%
2.7
US
Boston Scientific Corp
NYSE:BSX
42.7
32%
1.3
US
Stryker Corp
NYSE:SYK
28.4
16%
1.8
IE
Medtronic PLC
NYSE:MDT
22.9
17%
1.3
US
IDEXX Laboratories Inc
NASDAQ:IDXX
46.6
14%
3.3
US
Becton Dickinson and Co
NYSE:BDX
24.3
28%
0.9
DE
Siemens Healthineers AG
XETRA:SHL
18
16%
1.1
US
Edwards Lifesciences Corp
NYSE:EW
28.9
13%
2.2
US
Resmed Inc
NYSE:RMD
20.6
13%
1.6

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 299,800+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.